Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules

被引:22
作者
Bernardi, Stella [1 ,2 ]
Cavallaro, Marco [3 ]
Colombin, Giacomo [1 ]
Giudici, Fabiola [1 ,4 ]
Zuolo, Giulia [1 ,2 ]
Zdjelar, Adrian [1 ,5 ]
Dobrinja, Chiara [6 ]
De Manzini, Nicolo [1 ,6 ]
Zanconati, Fabrizio [1 ,7 ]
Cova, Maria Assunta [1 ,5 ]
Stacul, Fulvio [3 ]
Fabris, Bruno [1 ,2 ]
机构
[1] Univ Trieste, Dept Med Sci, Trieste, Italy
[2] Azienda Sanit Univ Giuliano Isontina, Inst Med Clin, Osped Cattinara, Trieste, Italy
[3] Azienda Sanit Univ Giuliano Isontina, Unit Radiol, Osped Maggiore, Trieste, Italy
[4] Univ Padua, Unit Biostat Epidemiol & Publ Hlth, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy
[5] Osped Cattinara, Azienda Sanit Giuliano Isontina, Dept Radiol, Trieste, Italy
[6] Osped Cattinara, Azienda Sanit Giuliano Isontina, Dept Gen Surg, Trieste, Italy
[7] Osped Cattinara, Azienda Sanit Giuliano Isontina, Dept Anat & Histopathol, Trieste, Italy
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 11卷
关键词
radiofrequency ablation (RFA); initial ablation ratio (IAR); efficacy; regrowth; retreatment; 5; years; thyroid;
D O I
10.3389/fendo.2020.582550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Radiofrequency ablation (RFA) has gained ground as an effective and well-tolerated technique to treat benign thyroid nodules. Most of the available studies have described the short-term outcomes of RFA, whereas there is a limited number of studies evaluating long-term issues, such as regrowth and the likelihood of retreatments. In addition, risk markers of regrowth and retreatment remain to be defined. The initial ablation ratio (IAR) is an index that measures the amount of ablation after RFA, which has been associated with technique efficacy (i.e. volume reduction >50% after 1 year from the procedure). This study aimed at evaluating i) IAR reproducibility and ii) IAR predictive value for RFA 5-year outcomes. Materials and Methods This is a retrospective single center study on patients with benign thyroid nodules treated with RFA and followed for 5 years after initial treatment. IAR interobserver reproducibility was evaluated with Bland-Altman method and Lin's concordance correlation coefficient (rho c). IAR predictive value for RFA 5-year outcomes was evaluated with linear and logistic regression models, as well as with Cox models, while receiver operating characteristic (ROC) analyses were used for cut-offs. Results We selected 78 patients with 82 benign thyroid nodules. The procedure significantly reduced nodule volume and this reduction was generally maintained over time. Technique efficacy was achieved in 92% of patients, while 23% of nodules regrew and 12% of nodules were retreated. Median IAR was 83%. Lin's concordance and Pearson's correlation coefficients suggested a good interobserver reproducibility of this index, consistent with the limits of agreement of the Bland-Altman plot. IAR was significantly associated with technique efficacy, 1- and 5-year volume reduction ratio, and with the likelihood of a retreatment, but not with nodule regrowth. ROC analyses showed that IAR cut-off was 49% for technique efficacy and 73% for retreatment. Conclusions Our results show for the first time that IAR is reproducible and that it predicts the volume reduction and the likelihood of a retreatment after 5 years from RFA.
引用
收藏
页数:8
相关论文
共 22 条
  • [1] Radiofrequency ablation for benign thyroid nodules
    Bernardi, S.
    Stacul, F.
    Zecchin, M.
    Dobrinja, C.
    Zanconati, F.
    Fabris, B.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (09) : 1003 - 1013
  • [2] Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group
    Bernardi, Stella
    Giudici, Fabiola
    Cesareo, Roberto
    Antonelli, Giovanni
    Cavallaro, Marco
    Deandrea, Maurilio
    Giusti, Massimo
    Mormile, Alberto
    Negro, Roberto
    Palermo, Andrea
    Papini, Enrico
    Pasqualini, Valerio
    Raggiunti, Bruno
    Rossi, Duccio
    Sconfienza, Luca Maria
    Solbiati, Luigi
    Spiezia, Stefano
    Tina, Doris
    Vera, Lara
    Stacul, Fulvio
    Mauri, Giovanni
    [J]. THYROID, 2020, 30 (12) : 1759 - 1770
  • [3] Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey
    Bernardi, Stella
    Dobrinja, Chiara
    Carere, Anna
    Giudici, Fabiola
    Calabro, Veronica
    Zanconati, Fabrizio
    de Manzini, Nicolo
    Fabris, Bruno
    Stacul, Fulvio
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 35 (01) : 150 - 158
  • [4] Radiofrequency Ablation Compared to Surgery for the Treatment of Benign Thyroid Nodules
    Bernardi, Stella
    Dobrinja, Chiara
    Fabris, Bruno
    Bazzocchi, Gabriele
    Sabato, Nicoletta
    Ulcigrai, Veronica
    Giacca, Massimo
    Barro, Enrica
    De Manzini, Nicolo
    Stacul, Fulvio
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [5] Prospective Study of Effectiveness of Ultrasound-Guided Radiofrequency Ablation Versus Control Group in Patients Affected by Benign Thyroid Nodules
    Cesareo, Roberto
    Pasqualini, Valerio
    Simeoni, Carla
    Sacchi, Marco
    Saralli, Erminio
    Campagna, Giuseppe
    Cianni, Roberto
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02) : 460 - 466
  • [6] Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
    Cooper, David S.
    Doherty, Gerard M.
    Haugen, Bryan R.
    Kloos, Richard T.
    Lee, Stephanie L.
    Mandel, Susan J.
    Mazzaferri, Ernest L.
    McIver, Bryan
    Pacini, Furio
    Schlumberger, Martin
    Sherman, Steven I.
    Steward, David L.
    Tuttle, R. Michael
    [J]. THYROID, 2009, 19 (11) : 1167 - 1214
  • [7] Long-Term Efficacy of a Single Session of RFA for Benign Thyroid Nodules: A Longitudinal 5-Year Observational Study
    Deandrea, Maurilio
    Trimboli, Pierpaolo
    Garino, Francesca
    Mormile, Alberto
    Magliona, Gabriella
    Ramunni, Maria Josefina
    Giovanella, Luca
    Limone, Piero Paolo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09) : 3751 - 3756
  • [8] Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study
    Deandrea, Maurilio
    Garino, Francesca
    Alberto, Mormile
    Garberoglio, Roberto
    Rossetto, Ruth
    Bonelli, Nadia
    Spiezia, Stefano
    De Santis, Massimo
    Monti, Salvatore
    Deiana, Maria Grazia
    Vincenzo, Toscano
    Cugini, Christian
    El Dalati, Ghassan
    Limone, Paolo Piero
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 180 (01) : 79 - 87
  • [9] Efficacy and Safety of Radiofrequency Ablation Versus Observation for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial
    Deandrea, Maurilio
    Sung, Jin Yong
    Limone, Paolo
    Mormile, Alberto
    Garino, Francesca
    Ragazzoni, Federico
    Kim, Kyu Sun
    Lee, Ducky
    Baek, Jung Hwan
    [J]. THYROID, 2015, 25 (08) : 890 - 896
  • [10] Dietrich CF, 2017, ULTRASCHALL MED, V38, pE16, DOI 10.1055/s-0043-103952